Nifty
Sensex
:
:
25244.75
82755.51
200.40 (0.80%)
700.40 (0.85%)

Pharmaceuticals & Drugs - Global

Rating :
54/99

BSE: 524735 | NSE: HIKAL

366.45
25-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  361.8
  •  372.7
  •  361.8
  •  366.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  189251
  •  69617588.15
  •  464.75
  •  309.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,520.82
  • 49.79
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,264.92
  • 0.38%
  • 3.58

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.85%
  • 1.67%
  • 16.57%
  • FII
  • DII
  • Others
  • 5.7%
  • 2.93%
  • 4.28%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.43
  • 3.44
  • -2.79

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.88
  • -0.45
  • -4.75

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.59
  • -3.79
  • -24.31

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.42
  • 44.47
  • 52.00

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.46
  • 3.85
  • 3.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.60
  • 15.91
  • 17.21

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
5.64
7.36
11.3
16.8
P/E Ratio
64.97
49.79
32.43
21.81
Revenue
1769
1860
2081
2397
EBITDA
267
328
405
510
Net Income
70
91
139
208
ROA
2.9
3.6
10.2
12.8
P/B Ratio
3.80
3.58
3.24
2.83
ROE
6
7.41
10.5
13.9
FCFF
-94
69
727
210
FCFF Yield
-1.75
1.28
13.52
3.9
Net Debt
797
747
102
-24
BVPS
96.32
102.38
113.1
129.3

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
552.40
514.10
7.45%
447.70
447.50
0.04%
452.90
434.90
4.14%
406.80
388.00
4.85%
Expenses
429.00
419.70
2.22%
375.60
382.80
-1.88%
378.00
377.30
0.19%
348.80
337.70
3.29%
EBITDA
123.40
94.40
30.72%
72.10
64.70
11.44%
74.90
57.60
30.03%
58.00
50.30
15.31%
EBIDTM
22.34%
18.36%
16.10%
14.46%
16.54%
13.24%
14.26%
12.96%
Other Income
0.50
0.50
0.00%
3.60
0.10
3,500.00%
0.40
1.00
-60.00%
0.50
0.90
-44.44%
Interest
17.90
15.30
16.99%
18.70
14.20
31.69%
18.80
13.10
43.51%
19.80
13.80
43.48%
Depreciation
37.70
32.30
16.72%
33.20
29.00
14.48%
31.70
28.60
10.84%
31.80
27.70
14.80%
PBT
68.30
47.30
44.40%
23.80
21.60
10.19%
24.80
16.90
46.75%
6.90
9.70
-28.87%
Tax
18.10
13.40
35.07%
6.60
5.50
20.00%
6.50
4.30
51.16%
1.80
2.80
-35.71%
PAT
50.20
33.90
48.08%
17.20
16.10
6.83%
18.30
12.60
45.24%
5.10
6.90
-26.09%
PATM
9.09%
6.59%
3.84%
3.60%
4.04%
2.90%
1.25%
1.78%
EPS
4.06
2.74
48.18%
1.39
1.30
6.92%
1.48
1.02
45.10%
0.41
0.56
-26.79%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,859.80
1,784.60
2,023.03
1,942.72
1,720.44
1,507.26
1,589.61
1,296.09
1,013.94
925.65
871.85
Net Sales Growth
4.22%
-11.79%
4.13%
12.92%
14.14%
-5.18%
22.65%
27.83%
9.54%
6.17%
 
Cost Of Goods Sold
837.30
824.66
1,107.03
996.39
908.37
776.32
853.82
698.90
508.88
464.89
427.14
Gross Profit
1,022.50
959.94
916.00
946.33
812.06
730.94
735.79
597.19
505.06
460.76
444.71
GP Margin
54.98%
53.79%
45.28%
48.71%
47.20%
48.49%
46.29%
46.08%
49.81%
49.78%
51.01%
Total Expenditure
1,531.40
1,517.57
1,765.96
1,602.16
1,397.55
1,234.11
1,291.48
1,054.35
815.48
744.81
689.44
Power & Fuel Cost
-
170.16
186.91
175.46
147.83
129.99
132.04
108.41
85.63
83.70
93.85
% Of Sales
-
9.53%
9.24%
9.03%
8.59%
8.62%
8.31%
8.36%
8.45%
9.04%
10.76%
Employee Cost
-
246.53
222.44
203.38
164.32
156.57
135.69
128.06
116.69
108.06
89.20
% Of Sales
-
13.81%
11.00%
10.47%
9.55%
10.39%
8.54%
9.88%
11.51%
11.67%
10.23%
Manufacturing Exp.
-
133.59
111.43
104.05
85.18
85.78
83.61
50.48
38.41
32.69
26.98
% Of Sales
-
7.49%
5.51%
5.36%
4.95%
5.69%
5.26%
3.89%
3.79%
3.53%
3.09%
General & Admin Exp.
-
86.99
80.23
60.89
38.68
43.05
35.77
28.33
30.77
26.86
24.93
% Of Sales
-
4.87%
3.97%
3.13%
2.25%
2.86%
2.25%
2.19%
3.03%
2.90%
2.86%
Selling & Distn. Exp.
-
29.54
30.89
40.71
31.46
20.45
23.36
22.52
18.02
17.09
18.92
% Of Sales
-
1.66%
1.53%
2.10%
1.83%
1.36%
1.47%
1.74%
1.78%
1.85%
2.17%
Miscellaneous Exp.
-
26.11
27.03
21.29
21.71
21.95
27.19
17.66
17.09
11.53
18.92
% Of Sales
-
1.46%
1.34%
1.10%
1.26%
1.46%
1.71%
1.36%
1.69%
1.25%
0.97%
EBITDA
328.40
267.03
257.07
340.56
322.89
273.15
298.13
241.74
198.46
180.84
182.41
EBITDA Margin
17.66%
14.96%
12.71%
17.53%
18.77%
18.12%
18.75%
18.65%
19.57%
19.54%
20.92%
Other Income
5.00
2.45
5.41
4.89
4.98
3.70
2.26
4.46
3.44
1.84
1.58
Interest
75.20
56.37
48.10
31.22
36.20
52.42
58.43
49.12
48.27
62.21
60.05
Depreciation
134.40
117.61
109.01
95.67
85.25
82.46
92.88
85.59
69.14
67.28
64.19
PBT
123.80
95.50
105.37
218.56
206.43
141.98
149.08
111.49
84.47
53.19
59.75
Tax
33.00
25.90
26.98
58.06
73.28
42.14
46.01
34.27
12.55
11.99
19.35
Tax Rate
26.66%
27.12%
25.61%
26.56%
35.50%
33.29%
30.86%
30.74%
15.64%
22.54%
32.38%
PAT
90.80
69.60
78.38
160.50
133.14
84.44
103.08
77.23
67.72
41.20
40.41
PAT before Minority Interest
90.80
69.60
78.38
160.50
133.14
84.44
103.08
77.23
67.72
41.20
40.41
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.88%
3.90%
3.87%
8.26%
7.74%
5.60%
6.48%
5.96%
6.68%
4.45%
4.63%
PAT Growth
30.65%
-11.20%
-51.17%
20.55%
57.67%
-18.08%
33.47%
14.04%
64.37%
1.95%
 
EPS
7.36
5.64
6.36
13.02
10.80
6.85
8.36
6.26
5.49
3.34
3.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,187.66
1,133.47
1,067.98
933.40
816.50
756.21
669.38
604.98
563.78
532.48
Share Capital
24.66
24.66
24.66
24.66
24.66
24.66
16.44
16.44
16.44
16.44
Total Reserves
1,163.00
1,108.81
1,043.32
908.74
791.84
731.55
652.95
588.54
547.34
516.04
Non-Current Liabilities
542.86
590.46
431.90
378.99
410.16
359.42
311.82
324.23
336.88
241.67
Secured Loans
422.85
489.88
286.68
262.89
303.40
297.84
296.63
320.15
296.61
201.44
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
27.99
24.22
79.59
77.94
73.43
48.74
15.65
14.30
10.22
11.71
Current Liabilities
756.63
661.55
828.15
703.31
652.77
659.02
616.17
470.29
397.36
530.07
Trade Payables
278.85
313.27
249.07
229.62
201.16
160.01
164.55
130.43
127.87
137.21
Other Current Liabilities
172.84
157.49
232.09
148.61
133.28
136.11
113.94
75.93
62.03
131.52
Short Term Borrowings
288.56
173.31
272.60
251.43
257.54
301.88
277.16
230.24
171.96
231.01
Short Term Provisions
16.39
17.49
74.39
73.65
60.80
61.03
60.52
33.69
35.49
30.33
Total Liabilities
2,487.15
2,385.48
2,328.03
2,015.70
1,879.43
1,774.65
1,597.37
1,399.50
1,298.02
1,304.22
Net Block
1,070.63
948.31
879.46
712.55
735.22
712.96
633.59
668.33
623.18
639.35
Gross Block
1,802.37
1,563.59
1,387.80
1,127.49
1,064.92
960.28
788.33
737.47
1,147.23
1,096.12
Accumulated Depreciation
731.74
615.27
508.33
414.94
329.70
247.31
154.73
69.14
524.05
456.77
Non Current Assets
1,520.53
1,446.46
1,304.78
1,090.58
1,048.22
888.17
851.29
792.71
807.83
791.16
Capital Work in Progress
414.34
412.15
294.78
254.24
160.82
78.69
117.88
62.76
66.13
61.66
Non Current Investment
5.35
5.30
0.64
0.61
0.68
1.02
2.60
3.62
3.12
3.12
Long Term Loans & Adv.
29.15
75.91
128.77
116.34
145.30
85.40
91.55
37.81
85.55
72.03
Other Non Current Assets
1.06
4.78
1.13
6.83
6.21
10.11
5.67
20.20
29.86
15.00
Current Assets
966.62
939.02
1,023.25
925.12
831.22
886.48
746.08
606.79
490.19
513.06
Current Investments
0.00
0.00
10.27
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
303.72
316.74
328.98
266.70
312.46
364.23
303.05
263.58
291.11
313.95
Sundry Debtors
550.34
441.78
437.72
485.53
340.44
349.72
287.37
256.47
112.31
127.97
Cash & Bank
20.88
59.55
49.09
36.81
63.57
31.74
27.22
16.46
19.16
13.70
Other Current Assets
91.68
17.93
23.07
12.29
114.74
140.79
128.43
70.27
67.62
57.43
Short Term Loans & Adv.
71.85
103.01
174.12
123.79
104.25
132.37
113.93
59.54
57.43
35.02
Net Current Assets
209.99
277.47
195.10
221.81
178.44
227.45
129.91
136.51
92.84
-17.02
Total Assets
2,487.15
2,385.48
2,328.03
2,015.70
1,879.44
1,774.65
1,597.37
1,399.50
1,298.02
1,304.22

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
186.72
315.31
293.73
229.02
284.93
185.59
138.81
163.48
185.61
102.18
PBT
95.50
105.37
218.56
206.43
141.98
149.08
111.49
80.27
53.19
59.75
Adjustment
174.87
163.13
126.27
126.99
136.17
158.81
140.35
126.88
133.68
126.82
Changes in Working Capital
-53.32
75.61
18.70
-57.89
46.49
-89.69
-87.16
-23.93
11.35
-71.33
Cash after chg. in Working capital
217.05
344.11
363.53
275.52
324.64
218.21
164.69
183.22
198.22
115.24
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-30.34
-28.80
-69.80
-46.50
-24.31
-32.62
-25.87
-19.73
-12.61
-13.06
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
-15.40
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-173.75
-292.34
-284.37
-156.20
-163.80
-124.59
-110.12
-102.17
-63.91
-42.89
Net Fixed Assets
-240.97
-293.16
-300.85
-155.99
-186.77
-132.76
-105.98
413.05
-55.58
-64.49
Net Investments
-0.05
5.61
-10.30
0.07
0.34
1.58
1.02
-0.50
0.00
0.00
Others
67.27
-4.79
26.78
-0.28
22.63
6.59
-5.16
-514.72
-8.33
21.60
Cash from Financing Activity
-27.00
-7.68
-5.56
-96.87
-100.86
-55.40
-24.79
-63.28
-123.63
-68.82
Net Cash Inflow / Outflow
-14.03
15.29
3.80
-24.05
20.27
5.59
3.90
-1.96
-1.93
-9.53
Opening Cash & Equivalents
26.73
11.44
7.64
31.68
11.41
5.82
1.93
3.89
6.23
15.75
Closing Cash & Equivalent
12.70
26.73
11.44
7.64
31.68
11.41
5.82
1.93
4.29
6.23

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
96.32
91.93
86.62
75.70
66.22
61.33
54.29
49.07
37.16
34.56
ROA
2.86%
3.33%
7.39%
6.84%
4.62%
6.11%
5.15%
5.02%
3.17%
3.12%
ROE
6.00%
7.12%
16.04%
15.22%
10.74%
14.46%
12.12%
12.74%
9.32%
9.81%
ROCE
7.82%
8.47%
15.21%
16.15%
12.44%
15.25%
12.81%
11.87%
11.92%
12.50%
Fixed Asset Turnover
1.06
1.37
1.54
1.57
1.49
1.82
1.70
1.10
0.83
0.82
Receivable days
101.46
79.34
86.73
87.62
83.56
73.14
76.34
65.09
46.88
45.07
Inventory Days
63.45
58.25
55.96
61.44
81.93
76.61
79.54
97.91
118.04
130.03
Payable days
131.04
92.70
87.68
86.55
52.18
44.26
48.94
56.69
62.74
67.85
Cash Conversion Cycle
33.87
44.89
55.01
62.51
113.32
105.49
106.94
106.31
102.18
107.25
Total Debt/Equity
0.69
0.66
0.63
0.65
0.79
0.87
0.95
0.99
1.10
1.28
Interest Cover
2.69
3.19
8.00
6.70
3.41
3.55
3.27
2.66
1.85
2.00

News Update:


  • Hikal passes ANVISA’s GMP audit for Jigani unit
    17th Jun 2025, 10:30 AM

    The inspection, carried out by ANVISA, Brazil GMP, was for multiple API’s which occurred from April 14th to April 18th, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.